| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8444394 | European Journal of Cancer | 2013 | 9 Pages |
Abstract
Association of 200 mg Tipifarnib with radiotherapy shows promising OS but no increase in TTP compared to historical data. FGFR1 and αvβ3 integrin are independent bad prognostic factors of OS and TTP.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Anne Ducassou, Emmanuelle Uro-Coste, Pierre Verrelle, Thomas Filleron, Alexandra Benouaich-Amiel, Vincent Lubrano, Jean-Christophe Sol, Marie-Bernadette Delisle, Gilles Favre, Solea Ken, Anne Laprie, Peter De Porre, Christine Toulas, Muriel Poublanc,